| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 16.685 | 31.431 | 39.725 | 42.756 | 51.006 |
| Total Income - EUR | - | - | - | - | - | 16.685 | 31.431 | 39.725 | 42.756 | 51.006 |
| Total Expenses - EUR | - | - | - | - | - | 182 | 6.625 | 10.959 | 25.590 | 19.363 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 16.503 | 24.806 | 28.767 | 17.166 | 31.643 |
| Net Profit/Loss - EUR | - | - | - | - | - | 16.002 | 24.374 | 28.369 | 16.739 | 30.113 |
| Employees | - | - | - | - | - | 0 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Catacris Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 16.201 | 40.493 | 49.997 | 66.283 | 96.157 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.672 | 1.780 | 1.028 | 1.019 | 1.254 |
| Cash | - | - | - | - | - | 14.529 | 38.714 | 48.969 | 65.264 | 94.902 |
| Shareholders Funds | - | - | - | - | - | 16.044 | 40.062 | 49.306 | 65.895 | 95.640 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 158 | 432 | 691 | 387 | 516 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Catacris Medical S.r.l.